ISHLT special reportReport of the ISHLT Working Group on Primary Lung Graft Dysfunction Part IV: Recipient-Related Risk Factors and Markers
Section snippets
Demographics
Existing evidence does not support an association between recipient age and the risk of PGD.1, 2, 3, 4 Although one study showed a younger mean age of patients with PGD versus those without, there was no adjustment for other potential confounders, such as underlying disease and use of cardiopulmonary bypass.5 The incidence of PGD and risk factors in pediatric lung transplant recipients are also poorly defined.6 Recipient gender (independent of the higher likelihood of sensitization from
Body Weight
Although two studies have identified obesity (body mass index [BMI] >27 to 30) as a significant risk factor for early mortality and longer intensive care unit stay, there are no specific studies of body weight and the incidence of PGD.7, 8
Hepatic Impairment
Among 62 patients with pulmonary arterial hypertension undergoing heart–lung transplantation, the early mortality of those with a serum bilirubin >2.1 mg/dl was 58% compared with 27% for those with a level between 1 and 2 mg/dl, and 16% in those with a normal
Re-transplantation
Short-term mortality is considerably increased for recipients with a second allograft, particularly those transplanted acutely for severe PGD20 and those who are non-ambulatory and ventilator-dependent.21 The occurrence of PGD has not been specifically documented in these reports. Among 15 recipients re-transplanted for obliterative bronchiolitis, only 2 died of PGD, suggesting that the risk of PGD is not substantially elevated.19
General Thoracic Procedures
A cohort of 18 recipients who had undergone earlier pleural
Mechanical ventilation
Pre-transplant mechanical ventilation does not appear to increase the risk of PGD.20, 31, 32
Obstructive Lung Disease
Chronic obstructive pulmonary disease (COPD) patients consistently have the lowest risk of PGD (with a reported incidence as low as 3%).2, 5, 33 In one study, patients with α1-anti-trypsin deficiency had a higher incidence of PGD (9%) and a somewhat longer duration of ventilation and intensive care unit stay compared with those of other emphysema patients. However, bilateral transplantation was also more frequent in the former group, suggesting that confounding variables other than diagnosis
Type of transplant
Most studies of the association between transplant type and PGD are limited by univariate analyses. It is possible that an apparent association between type of transplant and the risk of PGD may be confounded by the indication for lung transplantation and the use of cardiopulmonary bypass.
Role of cardiopulmonary bypass
The role of cardiopulmonary bypass as an independent or contributing factor for PGD remains controversial. Cardiopulmonary bypass causes a systemic, pro-inflammatory response with activation of cytokines, leukocytes and the complement cascade.57, 58, 59 The contribution of this inflammatory response and the requirements for transfusion on early graft function are less well defined. Limited retrospective series supporting both the deleterious and non-deleterious effects of cardiopulmonary bypass
Bleeding and transfusion-related lung injury
Transfusion of blood products may lead to pulmonary dysfunction.66 Free radicals, cytokines and humoral factors that are produced activate neutrophils and facilitate their interaction with the pulmonary endothelium. Activated neutrophils marginate through the endothelium where they are responsible for tissue injury by the release of free radicals and proteases.67
In the early era of lung and heart–lung transplantation, intra-operative and post-operative bleeding were significant causes of early
Surgical complications
Despite improvements in operative techniques, surgical problems may still lead to graft dysfunction in the early post-operative period.86 Technical complications leading to poor graft function generally include vascular anastomotic obstruction or improper orientation of the graft. Mechanical obstruction of the left atrial cuff, pulmonary vein or pulmonary artery due to anastomotic problems and/or subsequent thrombosis is the main source of graft dysfunction after lung transplantation.
Experimental and clinical biologic factors and markers in the recipient
Lung injury begins at least at a sub-clinical level at the time of donor brain-stem death as a result of a generalized inflammatory response, which correlates with subsequent indices of oxygenation in the recipient.118 Experimental and clinical evidence now suggests that reperfusion injury occurs in a biphasic pattern with the early phase of reperfusion injury depending primarily on donor characteristics, and the delayed phase of reperfusion occurring over the ensuing 24 hours depending
Summary
The lack of a clear definition of PGD in many large series of lung transplantation, including the ISHLT registry data, hampers the identification of recipient-related risk factors. Concomitant donor-related variables further confound these analyses. Based on the current body of literature, recipient-related risk factors that would require further study before any association can be stated include the type of procedure, the presence of hepatic dysfunction, and pleural adhesions and/or prior
References (163)
- et al.
The registry of the International Society for Heart and Lung Transplantationtwentieth official adult lung and heart–lung transplant report
J Heart Lung Transplant
(2003) - et al.
Clinical risk factors for primary graft failure following lung transplantation
Chest
(2003) - et al.
Respiratory failure after lung transplantation
Chest
(2003) - et al.
Acute pulmonary edema after lung transplantationthe pulmonary reimplantation response
Chest
(1999) - et al.
Early intervention after severe oxygenation index elevation improves survival following lung transplantation
J Heart Lung Transplant
(2001) - et al.
The registry of the International Society for Heart and Lung Transplantationfifth official pediatric report
J Heart Lung Transplant
(2002) - et al.
Impact of body weight on long-term survival after lung transplantation
Chest
(2002) - et al.
Nutritional assessment of the lung transplant patientbody mass index as a predictor of 90-day mortality following transplantation
J Heart Lung Transplant
(2001) - et al.
Cirrhosis as a risk factor for sepsis and deathanalysis of the National Hospital Discharge Survey
Chest
(2003) - et al.
New predictors of outcome in idiopathic pulmonary arterial hypertension
Am J Cardiol
(2005)
Clinical outcome after coronary artery revascularization and lung transplantation
Ann Thorac Surg
Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients
Ann Thorac Surg
Does the donor–recipient ABO blood group compatibility status predict subsequent lung transplantation outcomes?
J Heart Lung Transplant
Pre-transplant corticosteroid use and outcome in lung transplantation
J Heart Lung Transplant
Preoperative corticosteroids. A contraindication to lung transplantation?
Chest
Lung transplantation is warranted for stable, ventilator-dependent recipients
Ann Thorac Surg
Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry
Ann Thorac Surg
Does previous thoracic surgery increase perioperative risk in lung transplantation?
Transplant Proc
Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation
Chest
Outcome of lung transplantation in patients with mycetomas
Chest
Lung transplantation following lung volume reduction surgery
J Heart Lung Transplant
Heart–lung transplantation for Eisenmenger syndromeearly and long-term results
Ann Thorac Surg
Lung transplantation after long-term mechanical ventilationresults and 1-year follow-up
Chest
Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation
Ann Thorac Surg
Primary graft failure following lung transplantationpredictive factors of mortality
Chest
Lowering reperfusion pressure reduces the injury after pulmonary ischemia
Ann Thorac Surg
Controlled reperfusion and pentoxifylline modulate reperfusion injury after single lung transplantation
J Thorac Cardiovasc Surg
Controlled reperfusion protects lung grafts during a transient early increase in permeability
Ann Thorac Surg
Rapid reperfusion causes stress failure in ischemic rat lungs
J Thorac Cardiovasc Surg
Impact of pulmonary hypertension on outcome after single-lung transplantation
Ann Thorac Surg
Comparative outcome of heart–lung and lung transplantation for pulmonary hypertension
J Thorac Cardiovasc Surg
Beta-blocker prevented repeated pulmonary hypertension episodes after bilateral lung transplantation in a patient with primary pulmonary hypertension
J Thorac Cardiovasc Surg
Secondary pulmonary hypertension does not adversely affect outcome after single lung transplantation
J Thorac Cardiovasc Surg
Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome
J Thorac Cardiovasc Surg
Single vs bilateral, sequential lung transplantation for end-stage emphysemainfluence of recipient age on survival and secondary end-points
J Heart Lung Transplant
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosisa ten-year institutional experience
J Thorac Cardiovasc Surg
Inflammatory response to cardiopulmonary bypassmechanisms involved and possible therapeutic strategies
Chest
Inflammatory response to cardiopulmonary bypass
Ann Thorac Surg
Release of vasoactive substances during cardiopulmonary bypass
Ann Thorac Surg
Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation
Ann Thorac Surg
Early lung allograft function in twin recipients from the same donorrisk factor analysis
Ann Thorac Surg
Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation
J Thorac Cardiovasc Surg
Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults
Ann Thorac Surg
Acute and chronic effects of bilateral lung transplantation without cardiopulmonary bypass on the first transplanted lung
Ann Thorac Surg
Massive transfusion
Crit Care Clin
Non-cardiogenic pulmonary oedema in vascular surgery
Eur J Vasc Endovasc Surg
Blood loss and transfusion requirements in cystic fibrosis patients undergoing heart–lung or lung transplantation
J Cardiothorac Vasc Anesth
Clotting and fibrinolytic disturbance during lung transplantationeffect of low-dose aprotinin
J Thorac Cardiovasc Surg
Aprotinin reduces blood loss in lung transplant recipients
Ann Thorac Surg
Lung transplantation after previous thoracic surgical procedures
Ann Thorac Surg
Cited by (121)
History of Lung Transplantation
2023, Clinics in Chest MedicineECMO in thoracic transplantation
2022, Cardiopulmonary Bypass: Advances in Extracorporeal Life SupportInterobserver variability impairs radiologic grading of primary graft dysfunction after lung transplantation
2019, Journal of Thoracic and Cardiovascular Surgery67 - Pediatric Lung Transplantation
2019, Kendig's Disorders of the Respiratory Tract in ChildrenLung Transplantation in Interstitial Lung Disease
2018, Interstitial Lung DiseasePrimary Graft Dysfunction After Lung Transplantation
2017, Clinics in Chest Medicine